June 21st (Eastern Time) - $Singular Genomics (OMIC.US)$ is about to implement a 1-for-30 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from June 26th, 2024.
$Singular Genomics (OMIC.US)$ slipped 2.73% and closed at $0.321 on June 20th with a turnover of $12,008. $Singular Genomics (OMIC.US)$ now has a total market capitalization of $23.78 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.